Randomized Trial of Docetaxel Plus Cisplatin (DC) Versus Etoposide Plus Cisplotin (EC) in Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Park H.S. (Soonchunhang University Hospital) ;
  • Won J.H. (Soonchunhang University Hospital) ;
  • Lee S.J. (Chungang University Hospital) ;
  • Kim J.H. (Severance Hospital Yonsei University College of Medicine) ;
  • Ahn M.J. (Hanyang University Hospital) ;
  • Lee J.A. (Kangdong Sacred Heart Hospital) ;
  • Yim C.Y. (Chonbuk National University Hospital) ;
  • Kim C.S. (Inha University Hospital) ;
  • Mun C. (Aventis Pharma Korea) ;
  • Moon H. (Aventis Pharma Korea) ;
  • Lee Y.S. (Aventis Pharma Korea)
  • Published : 2003.12.01